Acorda to buy developer of Parkinson's treatment

September 24, 2014 1:26 PM

10 0

Updated 6:04 am, Wednesday, September 24, 2014

NEW YORK (AP) — Acorda Therapeutics Inc. plans to buy privately-held Civitas Therapeutics for $525 million in cash as the drugmaker seeks to expand into treatments for Parkinson's disease.

Also read: Italy says Amazon will pay $118 million to end tax dispute

Read more

To category page